文献速递免疫规划卫生政策与健康促进

埃塞俄比亚麻疹疫苗错过接种机会研究:5剂次瓶与灵活开瓶政策的整群随机评估(2021-2022)

Ethiopia missed opportunities for vaccination study: Cluster-randomized evaluation of 5-dose measles vaccine vials and a flexible open-vial policy, 2021-2022.
PubMed 文献 · Vaccine · 2026-08-20

结果显示联合干预显著提高9月龄及时接种率(ARD=18%,95%CI:7%,28%)和第二剂覆盖率(ARD=17%,95%CI:1%,34%),并降低浪费(ARD=-7%,95%CI:-14%,-1%)。

要点

  • 仅灵活开瓶政策未显著改善MCV1覆盖、及时性或MCV2覆盖。
  • 联合5剂次瓶干预显著提高MCV1及时性和MCV2覆盖率,并减少浪费。
  • 全国改用5剂次瓶估计每名全程接种儿童采购成本节省17%。

核心结论

  • 联合5剂次瓶与灵活开瓶政策可改善麻疹疫苗及时接种和第二剂覆盖,并减少浪费。

主要发现

  • 仅政策组MCV1覆盖与对照组相似(ARD=-1%,95%CI:-17%,15%),及时性和MCV2无显著差异。
  • 5剂次组MCV1覆盖变化小(ARD=1%,95%CI:-17%,18%),但9月龄及时接种率(ARD=18%,95%CI:7%,28%)和MCV2覆盖(ARD=17%,95%CI:1%,34%)显著上升,浪费下降(ARD=-7%,95%CI:-14%,-1%)。
  • 终点时5剂次组29%的卫生工作者每月开瓶≥10次,对照组无此情况;两个干预组照护者报告的麻疹相关错过接种机会减少11%。
  • 全国改用5剂次瓶估计每名全程接种儿童采购成本节省17%。

临床怎么用

  • 在麻疹疫苗接种点可考虑采用5剂次瓶联合灵活开瓶政策以提高及时接种和第二剂覆盖。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: In 2024, an estimated 95,000 people died from measles globally, largely from suboptimal coverage with the measles-containing vaccine (MCV). Health workers may defer vaccinating eligible children to avoid wasting doses from 10-dose MCV vials, which must be discarded six hours after opening. These missed opportunities for vaccination (MOV) reduce coverage and timeliness. Ethiopia, which provides MCV at 9 and 15 months, considered switching to 5-dose vials. METHODS: We conducted a 15-month, randomized controlled trial with a nested cross-sectional design in Ethiopia. Sixty woredas were randomized to: (1) policy-only, instructing health workers to open 10-dose vials for any number of eligible children, with additional stock for increased wastage; (2) 5-dose switch, combining this policy with replacement of 10-dose by 5-dose vials; or (3) control (routine 10-dose practice). Household and health-facility surveys at baseline and endline assessed effects on first-dose (MCV1) and second-dose (MCV2) coverage, MCV1 timeliness, and wastage. Generalized estimating equation models estimated net intervention effects versus control. We also estimated the government cost of a nationwide 5-dose switch. RESULTS: MCV1 coverage was similar between policy-only and control (adjusted risk difference [ARD] = -1%, 95%CI: -17%, 15%), with no significant differences in MCV1 timeliness or MCV2 coverage. In the 5-dose switch group, MCV1 coverage changed little (ARD = 1%, 95%CI: -17%, 18%), but timely MCV1 at 9 months (ARD = 18%, 95%CI: 7%, 28%) and MCV2 coverage (ARD = 17%, 95%CI: 1%, 34%) rose significantly, and wastage fell (ARD = -7%, 95%CI: -14%, -1%). By endline, 29% of 5-dose health workers opened vials ≥10 times monthly (none in control); caregivers in both intervention groups reported 11% fewer measles-related MOVs. A nationwide 5-dose switch was estimated to save 17% in procurement cost per fully vaccinated (two-dose) child. CONCLUSIONS: The combined 5-dose intervention improved MCV1 timeliness and MCV2 coverage and reduced wastage, addressing a key operational barrier and potentially supporting measles elimination in Ethiopia.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Wallace AS, Sugerman C, Getachew B, et al. Ethiopia missed opportunities for vaccination study: Cluster-randomized evaluation of 5-dose measles vaccine vials and a flexible open-vial policy, 2021-2022. Vaccine. 2026. PMID: 42623714. doi:10.1016/j.vaccine.2026.129065

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。